The week in health tech, explained in plain English.Get the free newsletter →
October 26, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

Apple Watch Series 12 Adds Heart Sensing and Readiness Score

Apple has unveiled the Apple Watch Series 12, introducing a Health Sensing System that the company says delivers the most accurate heart rate sensing of any wearable device, according to Becker's Hospital Review. The feature is built around new optical and electrical heart sensors paired with Apple's S11 chip.

The watch now measures heart rate every five seconds throughout the day and adds a readiness score, a metric that gauges how recovered a user is based on physiological signals. The upgrades continue Apple's steady move from consumer fitness tracking toward tools that edge closer to clinical monitoring.

For health systems and providers, more accurate and frequent heart data raises familiar questions about how consumer-generated readings fit into care. Continuous signals can surface early warning signs, but they also flood clinicians with data that needs context and validation. As Apple positions its wearable as a serious health device, the pressure grows for the industry to decide how patient-collected metrics get used, trusted, and acted on.

More in Health IT

Health IT

Does Long-Term AI Chatbot Use Cause Isolation? No One Knows

Researchers warn that long-term AI chatbot use may quietly drive social isolation, but a lack of access to usage data from AI companies makes the effect impossible to measure.

Why it matters: Hundreds of millions of people now use AI chatbots daily, yet the long-term mental health consequences remain unmeasured because the data sits locked inside private companies.

Health IT

How AI Aims to Give Physicians Their Attention Back

Health systems are deploying AI documentation and chart-summary tools to cut clerical work and let physicians focus on patients rather than screens.

Why it matters: Clerical burden is a leading driver of physician burnout, and AI that restores face-to-face attention could improve both clinician retention and patient trust.

Health IT

Moderna-Merck mRNA Cancer Vaccine Takes Center Stage at ESMO

Moderna and Merck's personalized mRNA cancer vaccine plus Keytruda headlined a marquee presentation at ESMO 2026 in Madrid, with Amgen's Imdelltra also in focus.

Why it matters: Proof that mRNA can power personalized cancer therapy would reshape oncology pipelines and investment across the industry.